MedCity News dissects E&Y’s “Biotechnology Report 2016”

MedCity NewsMedCity News dissects Ernst & Young’s “Biotechnology Report 2016” and concludes that it is still a strong sector, just not as strong as in recent years. Read the analysis here.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners